Celgene has received approval from the US Food and Drug Administration (FDA) for its drug 'Abraxane' to treat patients with late-stage adenocarcinoma of the pancreas. Adenocarcinoma is a sub-type of exocrine tumors which accounts for ...
GeneDx, a US-based genetic testing laboratory, has introduced a new suite of genetic tests for inherited cancer, including breast and colon cancer. To be marketed under OncoGeneDx brand, the new suite of genetic tests include a 26-gene ...
Tags: Genetic Tests, Inherited Cancer
Daiichi Sankyo Company has filed a supplemental new drug application for extended indication of anticancer agent Topotecin intravenous drip infusion 40mg, 100mg with the Japan's Ministry of Health, Labor and Welfare. Topotecin intravenous ...
Apple CEO Tim Cook spent more than an hour answering questions at the AllThingsD conference yesterday, but said little that was newsworthy. Which everyone should have expected, argued Carolina Milanesi, an analyst at Gartner who covers ...
Celgene International has obtained FDA priority review status for Abraxane (paclitaxel protein-bound particles for injectable suspension) supplemental new drug application (sNDA). The application covers the use of Abraxane and gemcitabine ...
Tags: Celgene sNDA, FDA Priority
Attendees at Furniture/Today's upcoming Bedding Conference here will be taking a tour of the TGen research facility that is on the front lines of the fight against pancreatic cancer and other deadly diseases. The tour of the TGen facility ...
Tags: Furniture, Furnishing
Nanomedicine company MagForce has commenced a research project with the University of Bremen, Center for Environmental Research and Sustainable Technology, for the development of magnetic iron oxide particles. The collaboration, which ...
Cancer patients in the north-east of England will be able to receive modern radiosurgery treatments without having to travel outside the region since the Northern Centre for Cancer Care (NCCC) in Newcastle –upon-Tyne announced that it ...
Tags: Cancer patients, NCCC, TrueBeam STx, medical linear accelerators
Apple raised CEO Tim Cook's salary by 55% for 2012 and awarded him a $2.8 million bonus, but said the chief executive's pay was still "significantly below the median" of comparable firms. "Mr. Cook remains significantly below the median ...
In the wake of his Belize neighbor's unsolved murder, John McAfee's lurch through the news damaged the reputation of his namesake, the security company McAfee Inc., a brand expert said Thursday. McAfee, 67, founded the firm in 1987 as ...
Tags: McAfee Inc, namesake, Intel, acquired
MIT researchers are using nanotechnology to help doctors detect cancer in their patients sooner, increasing their odds of beating the disease. To diagnose cancer, doctors look for specific proteins secreted by cancer cells. The problem ...
Tags: MIT, nanotechnology, detect cancer, specific proteins
US medical center, Mayo Clinic, has signed a pre-clinical research agreement with MagForce. Under the agreement, Mayo Clinic will begin a research program to investigate the preclinical efficacy of the MagForce's NanoTherm therapy in ...
Scientists at Princeton University say they have used nanotechnology to make tests to detect diseases,such as cancer and Alzheimer's,3 million times more sensitive. That means what researchers are calling a breakthrough in nanotechnology ...
Tags: nanotechnology, detect diseases, Princeton University, D2PA, Cancer
NewLink Genetics HyperAcute-Pancreas Immunotherapy (algenpantucel-L) has gained European orphan designation. Orphan designation provides NewLink with access to multiple incentives for drug development in EU. Incentives include decreased ...
Tags: algenpantucel-L, NewLink Genetics, HyperAcute-Pancreas Immunotherapy
Skuldtech and AB Science have discovered a new set of blood markers predictive of a higher survival rate in pancreatic cancer patients. The companies are also planning to use the new markers for future companion test commercialization ...
Tags: skuldtech, AB science, blood markers, pancreatic cancer patients